Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.3 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 30.45% year-over-year to 0.3, compared with a TTM value of 0.3 through Dec 2025, down 30.45%, and an annual FY2025 reading of 0.27, down 32.29% over the prior year.
  • Asset Utilization Ratio was 0.3 for Q4 2025 at Arcturus Therapeutics Holdings, down from 0.33 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.67 in Q3 2023 and bottomed at 0.02 in Q2 2021.
  • Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.35 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio plummeted 92.39% in 2021, then skyrocketed 1753.49% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2021, then skyrocketed by 1753.49% to 0.55 in 2022, then plummeted by 32.09% to 0.38 in 2023, then rose by 13.33% to 0.43 in 2024, then crashed by 30.45% to 0.3 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ARCT at 0.3 in Q4 2025, 0.33 in Q3 2025, and 0.38 in Q2 2025.